黄山胶囊收盘上涨1.47%，滚动市盈率42.91倍，总市值22.64亿元

Core Viewpoint - Huangshan Capsule's stock closed at 7.57 yuan, up 1.47%, with a rolling PE ratio of 42.91, marking a new low in 346 days, and a total market value of 2.264 billion yuan [1] Company Overview - Anhui Huangshan Capsule Co., Ltd. specializes in the research, production, and sales of gelatin hollow capsules and enteric-coated gelatin hollow capsules, being one of the earliest manufacturers in China with over 30 years of high-quality production history [1] - The company has a strong reputation in the pharmaceutical hollow capsule industry and is a member of the China Pharmaceutical Packaging Association, recognized for its contributions [1] Financial Performance - In the latest quarterly report for Q1 2025, the company achieved an operating income of 119 million yuan, a year-on-year increase of 0.53%, and a net profit of 18.837 million yuan, reflecting a year-on-year growth of 22.90% with a gross profit margin of 29.26% [2] Market Position - Huangshan Capsule's PE ratio of 42.91 is below the industry average of 51.42 and the industry median of 37.44, ranking 84th in the medical device sector [1][2] - The company’s market capitalization stands at 2.264 billion yuan, compared to the industry average market cap of 10.66 billion yuan [2]